Market
In Australia, Moringa oleifera (including leaf) is regulated as a novel food and is not permitted to be sold as a food or used as a food ingredient for retail sale following FSANZ’s rejection of Application A1294. As a result, moringa leaf powder positioned as a food/food ingredient faces a high likelihood of failing under the Imported Food Inspection Scheme at the border. Market presence is therefore most plausibly concentrated in regulated non-food pathways (e.g., complementary medicines) rather than mainstream food retail. Importers must manage both biosecurity import conditions (DAFF/BICON) and the applicable downstream regime (food vs therapeutic goods).
Market RoleImport-dependent market with primary demand in complementary medicines; retail food use restricted (novel food not permitted)
Domestic RoleLimited/regulated domestic availability; food channel constrained by novel food status
Market GrowthNot Mentioned
Risks
Regulatory Compliance HighAustralia (FSANZ/DAFF) does not permit Moringa oleifera (including leaf fresh/dried) to be sold as food or used as a food ingredient for retail sale following rejection of Application A1294; food-intended imports can be failed under the Imported Food Inspection Scheme and directed for destruction or export at the importer’s expense.Do not ship moringa leaf powder as food/food ingredient for retail sale unless and until it is permitted in the Code; obtain written regulatory advice on the intended pathway (food vs therapeutic goods) and align product positioning, labeling, and import declarations accordingly.
Border Enforcement HighNovel foods not listed in Schedule 25 (S25-2) are not permitted for retail sale and may be failed at the border under IFIS, creating high financial exposure (re-export/destruction) and supply disruption risk for food-intended consignments.Screen against the Food Standards Code novel foods permissions before purchase orders; pre-clear with compliance counsel and confirm DAFF/IFIS handling expectations for the declared end-use.
Documentation Gap MediumMisalignment between declared intended use (food vs therapeutic good), labeling, and supporting documents can trigger holds, rework, or enforcement action.Implement a pre-shipment document pack checklist covering intended-use statements, product composition, labeling proofs, and pathway-specific compliance evidence.
Logistics MediumEven when freight cost volatility is manageable for compact powders, border failure outcomes (re-export/destroy) create outsized landed-cost volatility compared with ordinary food ingredients.Contractually allocate border disposition risk; use small pilot consignments only after pathway confirmation.
FAQ
Can moringa leaf powder be sold in Australia as a food or food ingredient for retail sale?Based on FSANZ’s rejection of Application A1294 and DAFF’s Imported Food Notice (IFN 05-26), Moringa oleifera (including leaf) is not permitted to be sold as food or used as a food ingredient for retail sale in Australia unless it is approved and listed as a permitted novel food in Schedule 25 (S25-2) of the Food Standards Code.
What happens if moringa leaf powder is imported into Australia as food but is treated as a non-permitted novel food?DAFF states that if a novel food is not listed in Schedule 25 (S25-2) of the Code, imports of that food will be failed under the Imported Food Inspection Scheme and the importer may be directed to destroy or export the food at their own expense.
Is moringa allowed in Australia in any regulated pathway?Yes. TGA ARTG entries show products containing Moringa oleifera supplied as medicines (e.g., listed medicines). TGA guidance also states that listed medicines must be manufactured in accordance with recognised GMP standards (unless exempt).